Potential mediators include compromised nutritional status (e.g., hypoalbuminemia, reduced prealbumin levels), amplified systemic inflammation (e.g., elevated NLR, C-reactive protein, interleukin-6), and tumor-related characteristics such as total burden, metabolic activity, and microenvironmental alterations. This evidence concerns the gene IL6 and neoplasm.